Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis-Reference-Cited by-同舟云学术

Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis

Published:2023-05-31 Issue:12 Volume:149 Page:9979-9990
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Luo Meng,Jin Yao,Xu Chunjing,Chen Huihui,Zhang Kun,Chen Qiang,Jin Chencan,Lu Jinglu,Wang Jing,Huang Jia,Deng Hao,Jin Weili,Zheng Shu,Chen Yiding,Zhou Jiaojiao

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Medical Science and Technology Project of Zhejiang Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04908-7.pdf

Reference30 articles.

1. Abdel-Rahman O (2019) Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease: an individual patient data analysis of three clinical trials. Strahlenther Onkol 195(4):297–305

2. Audeh W, Blumencranz L, Kling H, Trivedi H, Srkalovic G (2019) Prospective validation of a genomic assay in breast cancer: the 70-gene MammaPrint assay and the MINDACT trial. Acta Med Acad 48(1):18–34

3. Cao L, Kirova MY, Xu C, Shen KW, Chen JY (2017) Role of PMRT in elderly patients with T1–2 and 1 to 3 positive nodes breast cancer. Radiother Oncol 123:S754

4. Chang JS, Lee J, Kim KH, Sohn JH, Kim SI, Park BW et al (2015) Do recent advances in diagnostic and therapeutic procedures negate the benefit of postmastectomy radiotherapy in N1 patients with a low risk of locoregional recurrence? Medicine (baltimore) 94(33):e1259

5. Chen X, Yu X, Chen J, Yang Z, Shao Z, Zhang Z et al (2013) Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1–T2 disease and one to three positive lymph nodes after mastectomy. Oncologist 18(2):141–147